🇺🇸 FDA
Pipeline program

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC)

WO42758

Phase 1 other active

Quick answer

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) for Metastatic Colorectal Cancer is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Metastatic Colorectal Cancer
Phase
Phase 1
Modality
other
Status
active

Clinical trials